Publications Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative Colitis Citation Ma C, Sandborn WJ, D'Haens GR, Zou G, Stitt LW, Singh S, Ananthakrishnan AN, Dulai PS, Khanna R, Jairath V, Feagan BG. Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020 Jul;18(8):1760-1768.e1. doi: 10.1016/j.cgh.2019.09.021. Epub 2019 Sep 20. PMID: 31546056; PMCID: PMC7992966. Abstract Background & aims: Little is known about the association between rectal bleeding and increased stool frequency with endoscopic findings in patients with mild to moderate ulcerative colitis (UC). We evaluated the associations between rectal bleeding or stool frequency and endoscopic remission in this population. Tags Biomarker, Complications, Diarrhea, Drug Therapy, Gastrointestinal Hemorrhage, IBD, inflammation, Inflammatory Bowel Disease, Mesalamine, Patient-reported Outcomes, Response to Therapy, therapeutic use, Treatment Outcome, Ulcerative Colitis Read More
